Perampanel CIII Tablets, 6mg, Rx only, 30 Tablets
Recalled by SUN PHARMACEUTICAL INDUSTRIES INC
Class II — moderate
Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
SUN PHARMACEUTICAL INDUSTRIES INC has recalled Perampanel CIII Tablets, 6mg, Rx only, 30 Tablets, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on July 1, 2026 and was initiated on June 17, 2026. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers Perampanel CIII Tablets, 6mg, Rx only, 30 Tablets, with approximately 3,456 30-count bottles affected. The company behind the recall is SUN PHARMACEUTICAL INDUSTRIES INC, based in Princeton, NJ. The FDA describes the product as: “Perampanel CIII Tablets, 6mg, Rx only, 30 Tablets, Mfd.by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 51672-4206-6”
Why was Perampanel CIII Tablets, 6mg, Rx only, 30 Tablets recalled?
According to the FDA, the stated reason for the recall is: “Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.”
What should you do?
If you think you may have bought Perampanel CIII Tablets, 6mg, Rx only, 30 Tablets, compare it against the product description and identifying codes (Lot AE01763, Expires 9/30/2027.) before using it. This recall is currently listed as ongoing.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact SUN PHARMACEUTICAL INDUSTRIES INC or your local health authority.
About this recall
This recall was distributed in NJ. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Full recall details
- Status
- Ongoing
- Date reported
- July 1, 2026
- Recall started
- June 17, 2026
- Distributed in
- NJ
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was Perampanel CIII Tablets, 6mg, Rx only, 30 Tablets recalled?+
According to the FDA: Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled…
How serious is this recall?+
Class II — moderate. Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
What should I do if I have Perampanel CIII Tablets, 6mg, Rx only, 30 Tablets?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: D-0628-2026. Information last synced from the FDA on July 11, 2026.